3 minute read
Chlamydia partners, retesting and reinfection
Treatment does not create immunity. Partner care and correctly timed follow-up reduce the chance of passing infection back and forth.
DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue an electronic prescription; each pharmacy decides whether it can dispense it.
Doctor reply in under 2 hours
Average doctor reply under 2 hours; at night and on public holidays it can take longer, always within 24 hours. A prescription only if appropriate.
EU-licensed doctors
Every case is reviewed by an EU-licensed doctor.
Electronic prescription
Each pharmacy decides whether it can dispense an approved prescription; some do not accept PDF prescriptions.
HOW IT WORKS
From consultation to collection
- 1
Consultation
Answer a secure medical questionnaire online.
- 2
Doctor reviews
An EU-licensed doctor personally assesses your case.
- 3
Prescription only if appropriate
The doctor replies in under 2 hours on average and issues a prescription only if it is clinically appropriate.
- 4
Collect at the pharmacy you choose
Take an approved prescription to the pharmacy you choose; each pharmacy decides whether it can dispense it.
A chlamydia diagnosis often brings two worries: how to tell partners and whether the infection will return. Chlamydia can be treated, but treatment does not create immunity. Reinfection is possible if an exposed partner has not been assessed or if a new exposure occurs.
Partner notification is practical healthcare
A sexual-health service can help identify which recent partners should be contacted based on local guidance and the history. Notification can often be anonymous. A positive result cannot reliably prove who had the infection first or when it was acquired, so the conversation should focus on testing and treatment rather than certainty or accusation.
Test of cure and retesting are different
A test of cure checks whether treatment cleared infection and is used in selected circumstances, such as pregnancy or when the regimen or response raises concern. Retesting later looks mainly for reinfection. Testing too soon after treatment may detect residual bacterial material, so follow the interval given by the service.
Reducing reinfection
Complete treatment, observe the advised no-sex interval, ensure relevant partners receive care and use condoms with new or untested partners. A wider STI screen may be offered because the same exposure can transmit more than one infection. Prevention is a shared plan, not a punishment.
When to seek help
Seek prompt in-person care for severe pelvic or testicular pain, fever, vomiting, pregnancy with concerning symptoms, eye pain after possible exposure, or feeling acutely unwell. Do not use leftover antibiotics or share treatment. Until a clinician confirms the appropriate interval after treatment, avoid sexual contact that could pass the infection on.
What to prepare for a medical review
A safe review includes the date and type of possible exposure, symptoms, pregnancy or breastfeeding, allergies, current medicines, and which anatomical sites may need testing. Partner notification and testing are part of care, not an accusation. A negative test from one site does not necessarily answer a question about another exposed site.
A calm next step
Ask the service for wording or anonymous-notification support if telling a partner feels difficult or unsafe. Put any repeat-test date in your calendar before closing the result message.
Clinical sources used: European Centre for Disease Prevention and Control chlamydia factsheet and local sexual-health service instructions.